SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-005604
Filing Date
2020-01-21
Accepted
2020-01-21 17:08:47
Documents
14
Period of Report
2020-01-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm202186-8_8k.htm   iXBRL 8-K 28708
2 EXHIBIT 99.1 tm202186d8_ex99-1.htm EX-99.1 12342
6 GRAPHIC tm202186d8_ex99-1img001.jpg GRAPHIC 7926
  Complete submission text file 0001104659-20-005604.txt   229439

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elan-20200121.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20200121_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20200121_pre.xml EX-101.PRE 22706
13 EXTRACTED XBRL INSTANCE DOCUMENT tm202186-8_8k_htm.xml XML 3489
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 20536958
SIC: 2834 Pharmaceutical Preparations